This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: Ralph M Kastner: Innovator in Antibiotic Development
Introduction
Ralph M Kastner is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of antibiotics, holding a total of 2 patents. His work has been instrumental in advancing medical science and improving healthcare outcomes.
Latest Patents
Kastner's latest patents include the development of Antibiotic A53868 and the process for its production. Antibiotic A53868 factor A is identified as N.sup.2 -glycyl-N-(2-methylene-2-phosphonoethyl)leucinamide. The formula for this compound is ##STR1##, and it is recognized for its utility as an antibiotic or as an intermediate in antibiotic production. The methods of preparing A53868 factor A involve fermentation of the microorganism Streptomyces luridus, specifically the strain S. luridus NRRL 15101.
Career Highlights
Ralph M Kastner is associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to focus on antibiotic research and development, contributing to the company's reputation for innovation in the healthcare sector.
Collaborations
Throughout his career, Kastner has collaborated with esteemed colleagues such as Stephen H Larsen and Earl E Ose. These partnerships have fostered a collaborative environment that enhances the research and development of new antibiotics.
Conclusion
Ralph M Kastner's contributions to antibiotic development through his patents and work at Eli Lilly and Company highlight his importance in the field of medical innovation. His research continues to impact the healthcare industry positively.